2011 annual financial data

Karyopharm Therapeutics 2011 Financial results

Direct answer

Revenue was 152,000 USD.

Operating income was -10,311,000 USD and net income was -10,311,000 USD.
Operating cash flow was -8,549,000 USD.

Get free Karyopharm Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
152,000 USD
Operating income
-10,311,000 USD
Net income
-10,311,000 USD
Operating cash flow
-8,549,000 USD